FDA now requires testosterone products to have blood clot risk warning on labels

June 21, 2014 11:56 AM

7 0

FDA now requires testosterone products to have blood clot risk warning on labels

Manufacturers of testosterone products are now required to include a general warning on labels to inform users of blood clot risks. FDA's investigation on stroke, heart attack and death risks linked with testosterone therapy is currently ongoing.(Photo : U.S. Drug Enforcement Administration)

Manufacturers of testosterone products are now required to include a general warning on labels to inform users of blood clot risks. FDA's investigation on stroke, heart attack and death risks linked with testosterone therapy is currently ongoing.

Read more

To category page

Loading...